U.S. unlikely to impose tariffs on generic drugs, easing concerns of Korean pharma companies
The Trump administration is unlikely to impose tariffs on generic drugs as part of its trade measures targeting pharmaceuticals. The move could ease concerns for Korean drugmakers, which count the United States as their largest export market.
